Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Agilent Technologies, Inc.
Agilent Technologies, Inc. News
Mar 19, 2025 - businesswire.com
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
Mar 10, 2025 - businesswire.com
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
Agilent Technologies, Inc. Quantitative Score
About Agilent Technologies, Inc.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Agilent Technologies, Inc. Earnings & Revenue
Agilent Technologies, Inc. Financials
Table Compare
Compare A metrics with: | |||
|---|---|---|---|
Earnings & Growth | A | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | A | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | A | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | A | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Agilent Technologies, Inc. Income
Agilent Technologies, Inc. Balance Sheet
Agilent Technologies, Inc. Cash Flow
Agilent Technologies, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Agilent Technologies, Inc. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 0.9680 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-04-23 | 0.248 | Quarterly |
| 2025-01-22 | 0.248 | Quarterly |
| 2024-10-23 | 0.236 | Quarterly |
| 2024-07-24 | 0.236 | Quarterly |
| 2024-04-24 | 0.236 | Quarterly |
Agilent Technologies, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Agilent Technologies, Inc. Executives
| Name | Role |
|---|---|
| Mr. Padraig McDonnell | Chief Executive Officer, President & Director |
| Mr. Robert W. McMahon C.M.A. | Senior Vice President & Chief Financial Officer |
| Mr. Henrik Ancher-Jensen | Senior Vice President and President of Order Fulfillment & Supply Chain |
| Dr. Simon May | SVice President & President of LDG |
| Mr. Parmeet Ahuja | Vice President of Investor Relations |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Padraig McDonnell | Chief Executive Officer, President & Director | Male | 1972 | 1.56M |
| Mr. Robert W. McMahon C.M.A. | Senior Vice President & Chief Financial Officer | Male | 1969 | 1.17M |
| Mr. Henrik Ancher-Jensen | Senior Vice President and President of Order Fulfillment & Supply Chain | Male | 1965 | 990.76K |
| Dr. Simon May | SVice President & President of LDG | 1973 | 882.86K | |
| Mr. Parmeet Ahuja | Vice President of Investor Relations | Male | -- |
Agilent Technologies, Inc. Insider Trades
| Date | 17 Mar |
| Name | Gonsalves Rodney |
| Role | V.P., Corporate Controller |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 1907.603 |
| Date | 28 Jan |
| Name | Gonsalves Rodney |
| Role | V.P., Corporate Controller |
| Transaction | Disposed |
| Type | G-Gift |
| Shares | 7148.983 |
| Date | 28 Jan |
| Name | Gonsalves Rodney |
| Role | V.P., Corporate Controller |
| Transaction | Acquired |
| Type | G-Gift |
| Shares | 7148.983 |
| Date | 14 Mar |
| Name | KOH BOON HWEE |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 1819 |
| Date | 14 Mar |
| Name | KOH BOON HWEE |
| Role | Director |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 546 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 17 Mar | Gonsalves Rodney | V.P., Corporate Controller | Disposed | S-Sale | 1907.603 |
| 28 Jan | Gonsalves Rodney | V.P., Corporate Controller | Disposed | G-Gift | 7148.983 |
| 28 Jan | Gonsalves Rodney | V.P., Corporate Controller | Acquired | G-Gift | 7148.983 |
| 14 Mar | KOH BOON HWEE | Director | Acquired | A-Award | 1819 |
| 14 Mar | KOH BOON HWEE | Director | Disposed | F-InKind | 546 |